Colgate-Palmolive (CL) Declares $0.42 Quarterly Dividend

Share on StockTwits

Colgate-Palmolive (NYSE:CL) announced a quarterly dividend on Thursday, January 10th, RTT News reports. Stockholders of record on Wednesday, January 23rd will be given a dividend of 0.42 per share on Friday, February 15th. This represents a $1.68 annualized dividend and a dividend yield of 2.72%.

Colgate-Palmolive has increased its dividend payment by an average of 3.4% annually over the last three years and has increased its dividend annually for the last 55 consecutive years. Colgate-Palmolive has a dividend payout ratio of 55.6% meaning its dividend is sufficiently covered by earnings. Research analysts expect Colgate-Palmolive to earn $3.03 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 55.4%.

Shares of NYSE CL opened at $61.82 on Friday. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $77.91. The firm has a market cap of $53.17 billion, a P/E ratio of 21.54, a P/E/G ratio of 2.94 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 26th. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. The firm had revenue of $3.85 billion during the quarter, compared to the consensus estimate of $3.89 billion. During the same period last year, the company earned $0.73 earnings per share. The company’s revenue for the quarter was down 3.2% on a year-over-year basis. Analysts anticipate that Colgate-Palmolive will post 2.96 EPS for the current year.

Several brokerages recently weighed in on CL. Argus reaffirmed a “buy” rating and set a $75.00 price target (up from $72.00) on shares of Colgate-Palmolive in a report on Tuesday, September 18th. Zacks Investment Research raised Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Tuesday, September 18th. Atlantic Securities started coverage on Colgate-Palmolive in a report on Thursday, September 20th. They set a “neutral” rating and a $71.00 price target for the company. SunTrust Banks cut Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the stock from $80.00 to $65.00 in a research report on Friday, October 26th. Finally, UBS Group set a $71.00 price objective on Colgate-Palmolive and gave the stock a “buy” rating in a research report on Wednesday, October 17th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $67.71.

COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive (CL) Declares $0.42 Quarterly Dividend” was reported by Macon Daily and is the property of of Macon Daily. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Read More: Trading Ex-Dividend Strategy

Dividend History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.

Leave a Reply